TEAR REPLACEMENT COMBINATION DRUGS IN THE TREATMENT OF DRY EYE SYNDROME
https://doi.org/10.21516/2072-0076-2018-11-3-63-69
Abstract
60 outpatients with weak and moderate dry eye syndrome were followed in order to perform a comparative efficiency evaluation of three tear replacement drugs: Stillavit, Vismed and Tears naturale. Changes in the condition of the eye were estimated using biomicroscopy data and diagnostic tests (including Schirmer test, Norn test, Lipkof test, lacrimal meniscus height, and fluorescein eye stain test). The patients were divided into 3 groups, each consisting of 20 patients, who respectively received instillations of two drops of the three drugs, 3 times a day for 40 days. The last examination was given on the 60th day of observation period since the drugs had been discontinued. As a result of treatment, positive changes were observed in all three observation groups. A pronounced improvement was achieved in the condition of the eyelids, conjunctiva and the cornea, as well as in the parameters of the diagnostic tests. In weak dry eye syndrome, full-scale moisturizing and formation of stable tear film is recommended, which is achievable with Vismed 0.18 %. In dry eye syndrome complicated by keratopathy, the therapeutic effect of the tear replacement drug must be strengthened by adding keratoprotectors, which is best achieved by the three-component eye solution, Stillavit. For citation: Jani Е.V., Seliverstova К.Е. Tear replacement combination drugs in the treatment of dry eye syndrome. Russian ophthalmological journal. 2018; 11 (3): 63-9 (In Russian). doi: 10.21516/2072-0076-2018-11-3-63-69.
About the Authors
A. V. Jani
Moscow Helmholtz Research Institute of Eye Diseases
Russian Federation
Russian Federation
E. A. Seliverstova
Moscow Helmholtz Research Institute of Eye Diseases
Russian Federation
Russian Federation
References
1. Бржеский В.В., Сомов Е.Е. Синдром «сухого глаза». Санкт-Петербург: Аполлон; 1998. Brzhesky V.V., Somov E.E. Syndrome of "dry eye". St.-Petersburg: Apollon; 1998 (in Russian).
2. Егоров А.Е., Егорова Г.Б., Муратова Н.В. Современные аспекты терапии синдрома сухого глаза. Кремлевская медицина. 2002; 3: 49-50.
3. Слонимский Ю.Б., Чернакова Г.М., Корецкая Ю.М. Применение препарата Видисик в лечении синдрома «сухого глаза». РМЖ Клиническая офтальмология. 2002; 1: 15-6.
4. Бржеский В.В., Садовникова Н.Н., Прозорная Л.П. Новый препарат искусственной слезы ОКСИАЛ в лечении больных с синдромом «сухого глаза». РМЖ Клиническая офтальмология. 2006; 4: 151-4.
5. Яни Е.В., Майчук Ю.Ф. Применение глазных капель «Хило-комод» в качестве базовой терапии синдрома «сухого глаза». Новые лекарственные препараты: экспресс-информация. 2007; 12: 42-3.
6. Нагорский П.Г., Белкина В.В., Нестерова Л.Ю. Влияние слезозаместительной терапии (препарат Хилабак 0,15%) на выраженность синдрома «сухого глаза» при ношении контактных линз у детей и подростков. Российский офтальмологический журнал. 2011; 4(2): 32-6.
7. Rouen P A, White M L. Dry Eye Disease: Prevalence, Assessment, and Management. Home Health Care Now. 2018; 36: 74-83. doi: 10.1097/NHH.0000000000000652
8. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye Work Shop. The ocular surface. 2007; 5: 93-107.
9. Stern M.E., Schaumburg C.S, Pflugfelder S.C. Dry eye as a mucosal autoimmune disease. Int. Rev. Immunol. 2013; 32: 19-41. doi: 10.3109/08830185.2012.748052
10. Nuzzi R., Finazzo C., Cerruti A. Adverse effects of topical antiglaucomatous medications on the conjunctiva and the lachrymal response. International Ophthalmology. 1998; 22: 31-5.
Review
For citations:
Jani A.V., Seliverstova E.A. TEAR REPLACEMENT COMBINATION DRUGS IN THE TREATMENT OF DRY EYE SYNDROME. Russian Ophthalmological Journal. 2018;11(3):63-69. (In Russ.) https://doi.org/10.21516/2072-0076-2018-11-3-63-69
Views:
1106
Email this article 